(PR-inside.com) Oxford BioTherapeutics Ltd (Oxford BioTherapeutics) is a biotechnology company. It focuses on the development antibody drug conjugates (ACDs) for the treatment of wide variety of cancers. The company developed a technology that targets the delivery of cancer medicines. Oxford BioTherapeutics also provides target and biomarker discovery and screening services to pharmaceutical and biotechnology companies. The OGAP platform of the company discovers diagnostic targets for the company's partners. The company's other technologies include antibody development, antibody 'arming' and cancer therapy development. It works in collaboration with various leading companies such as Seattle Genetics, BioWa, Sanofi, GlaxoSmithKline, Amgen, Medarex and Biosite for ..